© 2003 by Oxford University Press
Journal of the National Cancer Institute, Vol. 95, No. 5, 352,
March 5, 2003
© 2003 Oxford University Press
NEWS |
Awards, Appointments, Announcements
Raynard S. Kington, M.D., Ph.D., has been appointed deputy director of the National Institutes of Health. Kington was previously associate director for Behavioral and Social Sciences Research and director of the NIH Office of Behavioral and Social Sciences Research. He has also served as acting director for the National Institute on Alcohol Abuse and Alcoholism.
Kington replaces Ruth Kirschstein, M.D., who will become the senior adviser to NIH Director Elias A. Zerhouni, M.D.
Marc Rosenblum, M.D., has been named chairman of the Department of Pathology at Memorial Sloan-Kettering Cancer Center in New York. He was previously acting chairman of the department. He has also served as chief of Memorial Sloan-Kettering’s Neuropathology and Autopsy Service.
Margaret A. Chesney, Ph.D., has been named first deputy director of the National Center for Complementary and Alternative Medicine of the National Institutes of Health.
Chesney will help formulate, guide, and oversee the management of all NCAAM-funded extramural centers, investigator-initiated research, research contracts, fellowships, and training and career awards.
Prior to joining NCCAM, Chesney was co-director of the Center for AIDS Prevention Studies and director of the behavioral medicine and epidemiology core of the Center for AIDS Research at the University of California at San Francisco.
Rudolf Jaenisch, M.D., of the Whitehead Institute in Cambridge, Mass., and Erwin Wagner, Ph.D., of the Research Institute of Molecular Pathology in Vienna, Austria, have been selected to receive the 2003 Charles Rodolphe Brupbacher Prize in Cancer Research. The prize will be awarded in March at the sixth scientific symposium of the Charles Rodolphe Brupbacher Foundation in Zurich, Switzerland.
David G. Nathan, M.D., president emeritus of the Dana-Farber Cancer Institute in Boston, will be awarded the 2003 John Howland Medal in May at the American Pediatric Society’s annual meeting in Seattle. The award is given annually to individuals whose achievements have helped advance the field of pediatrics.
|
Nathan’s work on thalassemia, a condition in which the body fails to make hemoglobin properly, has led to new techniques to treat and prevent the disease.
Carolyn M. Clancy, M.D., has been appointed director of the Agency for Healthcare Research and Quality. She was previously acting director of the agency and has also served as director of the agency’s Center for Outcomes and Effectiveness Research and director of the Center for Primary Care Research.
David A. Scott, Ph.D., has been elected president of the International Society for the Prevention of Tobacco Induced Diseases. Scott is an assistant professor of oral biology at the University of Manitoba in Canada.
Anthony J. Hedley, M.D., has been elected deputy president of the society. He is a professor at the University of Hong Kong Medical Center.
Three physicians have been appointed to faculty positions at the Roswell Park Cancer Institute in Buffalo, N.Y.
Aidnag Diaz, M.D., was named to the Department of Radiation Medicine. Diaz was previously assistant professor of radiation oncology at the University of Washington Medical Center in Seattle.
Roger Smith, M.D., and Ahmed Adelhalim, M.D., were named to the Department of Diagnostic Imaging. Smith was previously with the Ide Group in Rochester, N.Y. Adelhalim was previously an instructor and fellow in the Department of Radiology at the University of Rochester Medical Center in New York.
The Institute for Cancer Research at the University of North Texas Health Science Center has appointed six researchers to faculty positions. The new appointments are: Kenneth W. Brunson, Ph.D., director; Alakananda Basu, Ph.D., deputy director; Porunelloor Mathew, Ph.D., associate director for basic research; Ray Page, Ph.D., associate director for cancer development therapeutics and translational research; Michael Ross, M.D., associate director for clinical oncology; and Fernando Treviño, Ph.D., associate director for Cancer Preventive Medicine in Public Health.
Ronald P. Rapini, M.D., has been appointed chairman of the Department of Dermatology at the University of Texas M. D. Anderson Cancer Center and the University of Texas Medical School in Houston.
Rapini is also chairman of dermatology at Memorial Hermann Hospital and Lyndon B. Johnson General Hospital, both in Houston. He is a former professor and chairman of the Department of Dermatology at Texas Tech University Medical School in Lubbock.
Bernard A. Schwetz, Ph.D., has been named acting director of the Health and Human Services Office for Human Research Protections. Schwetz is former senior adviser for science at the U.S. Food and Drug Administration and has also served as the FDA’s acting deputy commissioner. In addition, Schwetz has served as acting director of the Environmental Toxicology Program at the National Institute of Environmental Health Sciences.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||